Two telehealth firms turn to branded Zepbound as restrictions loom on copies Reuters.com
Category: GLP-1 News
Tris Pharma eyes approval after pain drug triumphs in second Phase III trial
Tris Pharma previously announced data from another Phase III trial of cebranopadol, which also met its…
Natural alternative to Ozempic brings results without side effects – New Atlas
Natural alternative to Ozempic brings results without side effects New Atlas
Support Group For Those Taking/Considering Weight Loss Drugs Monthly On First Wednesdays At Unitarian Church – Los Alamos Daily Post
Support Group For Those Taking/Considering Weight Loss Drugs Monthly On First Wednesdays At Unitarian Church Los Alamos…
Even your weight loss drugs aren’t safe from tariffs – Quartz
Even your weight loss drugs aren’t safe from tariffs Quartz
U.S. judge ruling for FDA bars copies of Lilly weight loss drug – PharmaLive
U.S. judge ruling for FDA bars copies of Lilly weight loss drug PharmaLive
Novo Enters the Ring in Legal Fight Against GLP-1 Compounders – BioSpace
Novo Enters the Ring in Legal Fight Against GLP-1 Compounders BioSpace
TC BioPharm signs LoI to acquire ophthalmic pharma company
TC BioPharm has signed a non-binding LoI to acquire a pharma company focused on commercialising intraocular…
US judge denies injunction to stop bar on copies of Lilly weight loss drug – Reuters
US judge denies injunction to stop bar on copies of Lilly weight loss drug Reuters
In FDA obesity drug battle with compounders, Texas court allows Novo Nordisk to weigh in – FiercePharma
In FDA obesity drug battle with compounders, Texas court allows Novo Nordisk to weigh in FiercePharma